Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Cancer. 2012 Jul 6;119(2):429–437. doi: 10.1002/cncr.27688

Table 8.

FKSI comparisons by ECOG Performance Status and Number of Comorbid Conditions

NFKSI-19 FKSI-15 NFKSI-DRS-13 FKSI- DRS-9

n M SD p- value* M SD p- value* M SD p- value* M SD p- value*
ECOG

 I have normal activity without symptoms 1268 63.7 9.0 <.0001 49.8 7.2 <.0001 43.7 6.3 <.0001 31.4 4.6 <.0001
 I have some symptoms but do not require bed rest during the waking day 615 54.4 10.6 <.0001 42.0 8.5 <.0001 37.1 7.8 <.001 26.8 5.5 <.0001
 I require bed rest for less than 50% of the waking day 87 45.4 11.7 .66 35.2 9.3 .77 31.3 8.6 .85 23.2 6.1 .76
 I require bed rest for more than 50% of the waking day 25 44.4 12.3 34.7 9.4 31.6 8.8 23.5 6.3

Comorbid Conditions

 0 448 65.6 7.8 .0002 51.3 6.4 .0001 45.2 5.3 <.0001 32.6 3.8 <.0001
 1–2 694 63.4 8.6 <.0001 49.5 6.9 <.0001 43.6 6.0 <.0001 31.2 4.2 <.0001
 3 257 58.9 8.9 <.0001 45.8 7.2 <.0001 40.6 6.4 <.0001 29.2 4.4 <.0001
 4+ 601 51.6 12.0 39.9 9.5 35.0 8.6 25.3 6.2
*

Note: p-values are tests for differences between adjacent categories.

HHS Vulnerability Disclosure